We are looking for children at least 2 years of age but under 18 to join a CD medical research study to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or Inflammatory bowel disease (including associated symptoms such as painful joints, inflammation of the bowel or intestine, rectal pain, malnutrition and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local research study is testing a potential new medication to see if it may reduce recurrent diarrhea, joint pain, cramps, malnutrition, and/or anemia associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2 to 17 years of age to join a CD medical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or IBD (including associated symptoms such as chronic diarrhea, perianal fistula, constant need to poop, weight loss and/or eye pain), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local research is testing a potential new medication to see if it may reduce rectal bleeding, growth failure, cramps, weight loss, and/or liver disease associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children and teens 2–17 years of age to join a clinical research to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or Crohn’s and ulcerative colitis (including associated symptoms such as rectal pain, abdominal cramps, bloody stool, weight loss and/or eye pain), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce abdominal cramping, perianal fistula, abdominal pain, malnutrition, and/or liver disease associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for children aged 2 to 17 years to join a CD trial to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or Crohn’s and ulcerative colitis (including associated symptoms such as abdominal pain or cramping, fistula, bloody stool, malnutrition and/or canker sores), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce tiredness, abdominal cramps, bloody stool, malnutrition, and/or liver disease associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children 2 to 17 years old to join a Crohn’s disease (CD) clinical research to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or Crohn’s and UC (including associated symptoms such as tiredness, kidney stones, bloody stool, weight loss and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce joint pain, inflammation of the bowel or intestine, cramps, chronic fatigue, and/or joint pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.